Milbemycin oxime Praziquantel Chew Alfamed 25.0 mg / 250.0 mg chewable tablets for large dogs
Milbemycin oxime Praziquantel Chew Alfamed 25.0 mg / 250.0 mg chewable tablets for large dogs
Authorised
- Milbemycin oxime
- Praziquantel
Product identification
Medicine name:
Milbemycin oxime Praziquantel Chew Alfamed 25.0 mg / 250.0 mg chewable tablets for large dogs
Milbemycin oxime Praziquantel Chew Alfamed 25,0 mg / 250,0 mg comprimés à croquer pour grands chiens
Milbemycin oxime Praziquantel Chew Alfamed 25,0 mg / 250,0 mg kauwtablet voor grote honden
Milbemycin oxime Praziquantel Chew Alfamed 25,0 mg / 250 mg Kautabletten für große Hunde
Active substance:
- Milbemycin oxime
- Praziquantel
Target species:
-
Dog (large)
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Milbemycin oxime25.00/milligram(s)1.00Tablet
-
Praziquantel25.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AB51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- 1 box with 1 blister, each blister contains 2 chewable tablets
- 1 box with 2 blisters, each blister contains 2 chewable tablets
- 1 box with 12 blisters, each blister contains 2 chewable tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 19(1) of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Alfamed
Marketing authorisation date:
Manufacturing sites for batch release:
- Alfamed
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V663733
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0413/003
Concerned member states:
-
Belgium
-
France
-
Germany
-
Ireland
-
Italy
-
Norway
-
Portugal
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.